Clinical Trial Update: Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Actinic Cheilitis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating methyl aminolevulinate photodynamic therapy for actinic cheilitis, with and without Er:YAG laser pretreatment, has completed. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Cheilitis

Drugs mentioned

• Methyl aminolevulinate photodynamic therapy (methyl aminolevulinate)

Snippet

Sponsor: Dong-A University | Conditions: Actinic Cheilitis | Phase 1 | Status: COMPLETED